Sven Ante Lundberg
Chief Scientific Officer, CRISPR Therapeutics.
Companies
- Yarrow Bioscience, Inc.Board member Jul 29, 2026 to now1
- Q32 Bio Inc.Board member Mar 27, 2024 to now2
- Vor Biopharma Inc.Board member Feb 4, 2021 to now3
- Merus N.V.Board member Jan 2, 2020 to now4
- Merus N.V.Chief executive officer Jan 2, 2020 to now4
- Merus N.V.President Jan 2, 2020 to now4
- CRISPR TherapeuticsChief Scientific Officer Oct 18, 2016 to Feb 10, 20175
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Q32 Bio Inc. QTTB1,200 shares6$9.4K at $7.81Mar 27, 2024
- Merus N.V.0 shares7Dec 12, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 12, 2025U 9,192 shares at $97.00 of Merus N.V.7
- Dec 12, 2025U 9,192 shares at $97.00 of Merus N.V.7
- Dec 12, 2025U 9,191 shares at $97.00 of Merus N.V.7
- Dec 12, 2025U 9,191 shares at $97.00 of Merus N.V.7
- Dec 12, 2025U 16,372 shares at $97.00 of Merus N.V.7
- Dec 12, 2025U 30,297 shares at $97.00 of Merus N.V.7
- Nov 25, 2025Gift 2,539 shares of Merus N.V.8
- Nov 25, 2025Gift 2,539 shares of Merus N.V.8
- Nov 25, 2025Gift 2,539 shares of Merus N.V.8
- Nov 25, 2025Gift 2,538 shares of Merus N.V.8
- Nov 25, 2025Gift 24,229 shares of Merus N.V.8
- Nov 25, 2025Gift 22,449 shares of Merus N.V.8
- Nov 25, 2025Gift 52,369 shares of Merus N.V.8
- Nov 25, 2025Gift 12,215 shares of Merus N.V.8
- Nov 25, 2025Gift 14,198 shares of Merus N.V.8
- Nov 25, 2025Gift 30,297 shares of Merus N.V.8
- Nov 25, 2025Gift 30,297 shares of Merus N.V.8
- Apr 17, 2025Exercised options 26,500 shares at $13.52 of Merus N.V.9
- Apr 17, 2025Exercised options 3,797 shares at $12.54 of Merus N.V.9
- Feb 19, 2025Gift 40,601 shares of Merus N.V.10
- Feb 19, 2025Gift 40,601 shares of Merus N.V.10
- Feb 13, 2025Exercised options 16,372 shares at $24.43 of Merus N.V.11
- Nov 3, 2022Bought 14,706 shares at $14.38 of Merus N.V.12
- Aug 22, 2022Bought 5,826 shares at $22.92 of Merus N.V.13
- Aug 19, 2022Bought 704 shares at $22.99 of Merus N.V.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARQ32 Bio Inc., Board member
- 3SEC EDGARVor Biopharma Inc., Board member
- 4SEC EDGARMerus N.V., Board member
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Nov 28, 2025
- 9SEC EDGARForm 4 filed Apr 21, 2025
- 10SEC EDGARForm 4 filed Feb 21, 2025
- 11SEC EDGARForm 4 filed Feb 18, 2025
- 12SEC EDGARForm 4 filed Nov 3, 2022
- 13SEC EDGARForm 4 filed Aug 23, 2022
- 14SEC EDGARForm 4 filed Aug 22, 2022